FTC requires divestitures in DaVita’s purchase of DSI Renal
The Federal Trade Commission Friday approved DaVita’s 689 million-dollar buy of rival dialysis company DSI, conditioned on the sale of 29 outpatient dialysis clinics across the U.S. to Dialysis Newco.Washington –...To view the full article, register now.
Already a subscriber? Click here to view full article